CXCL10 and neoplasm: By enabling localized, sustained secretion of chemokines such as CXCL10 directly from tumour cells, this approach promotes immune cell recruitment and trafficking while avoiding systemic cytokine exposure, potentially minimizing off-target effects and toxicity.